| [1] |
Panteli M, Papakostidis C, Dahabreh Z, et al. Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis[J]. Knee, 2013, 20(5): 300-309.
|
| [2] |
刘江峰．口服氨甲环酸在减少全膝关节置换术后出血的作用[J]．检验医学与临床，2018，15(17):2578-2581.
|
| [3] |
叶一林，柴卫兵，卢宏章，等．人工膝关节置换术中静脉注射氨甲环酸对减少术后失血的临床观察[J]．中国矫形外科杂志，2016，24(21):1964-1967.
|
| [4] |
曾兵，刘刚，贺志盛，等．氨甲环酸关节腔内注射联合置换后3 h夹闭引流管对膝关节单髁置换失血量的影响[J]．中国组织工程研究，2016，20(22):3197-3204.
|
| [5] |
武辉，全健，雷斌，等．关节腔和静脉联合应用氨甲环酸对人工全膝关节置换术疗效及出血量的影响[J]．安徽医药，2018，22(10):1983-1986.
|
| [6] |
方志辉，杨华清，李兵奎，等．氨甲环酸应用于膝关节置换术随机对照安慰剂试验的Meta分析[J/CD]．中华临床医师杂志(电子版)，2012，6(24):8173-8179.
|
| [7] |
黄秋，黎晓雨，刘凯，等．全膝关节置换术中口服氨甲环酸疗效与安全性的Meta分析[J]．重庆医学，2018，47(24):3194-3203.
|
| [8] |
赵旻暐，李子剑，张克．氨甲环酸在人工全膝关节置换术中的应用[J/CD]．中华关节外科杂志(电子版)，2014，8(2):236-239.
|
| [9] |
Surgeons AAoO. AAOS Clinical Practice Guideline and Systematic Review Methodology. In.:
|
| [10] |
Fillingham YA RD, Jevsevar DS, Yates AJ, et al. The efficacy of tranexamic acid in total hip arthroplasty: a network meta-analysis[J]. J Arthroplasty, 2018, 33(10):3083-3089.
|
| [11] |
Fillingham YA RD, Jevsevar DS, Yates AJ, et al. The efficacy of tranexamic acid in total knee arthroplasty: a network meta-analysis[J]. J Arthroplasty, 2018, 33(10):3090-3098.
|
| [12] |
Maniar R, Kumar G, Singhi T, et al. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients[J]. Clini Orthop Relat Res, 2012, 470(9):2605-2612.
|
| [13] |
Wong J, Abrishami A, El Beheiry H, et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trialu[J]. J Bone Joint Surg, 2010, 92(15): 2503-2513.
|
| [14] |
Carvalho LH Jr., Frois Temponi E, Machado Soares LF, et al. Bleeding reduction after topical application of tranexamic acid together with Betadine solution in total knee arthroplasty. A randomised controlled study[J]．Orthop Traumatol-Surg Res, 2015, 101(1): 83-87.
|
| [15] |
Sarzaeem MM, Razi M, Kazemian G, et al. Comparing efficacy of three methods of tranexamic acid administration in reducing hemoglobin drop following total knee arthroplasty[J]. J Arthroplasty, 2014, 29(8): 1521-1524.
|
| [16] |
Barrachina B, Lopez-Picado A, Remon M, et al. Tranexamic acid compared with placebo for reducing total blood loss in hip replacement surgery: a randomized clinical trial[J]. Anesth Analg, 2016, 122(4): 986-995.
|
| [17] |
Lin P, Hsu C, Huang C, et al. The blood-saving effect of tranexamic acid in minimally invasive total knee replacement: is an additional pre-operative injection effective? [J]. J Bone Joint Surg Br, 2012, 92(7):932-936.
|
| [18] |
Hourlier H, Fennema P. Single tranexamic acid dose to reduce perioperative morbidity in primary total hip replacement: a randomised clinical trial[J]. Hip Int, 2014, 24(1):63-68.
|
| [19] |
Imai N, Dohmae Y, Suda K, et al. Tranexamic acid for reduction of blood loss during total hip arthroplasty[J]. J Arthroplasty, 2012, 27(10):1838-1843.
|
| [20] |
Fillingham YA, Ramkumar DB, Jevsevar DS, et al. The safety of tranexamic acid in total joint arthroplasty：a direct meta-analysis[J/OL]. J Arthroplasty, 2018, 33(10):3070-3082. e1. doi: 10.1016/j.arth.2018.03.031. |
| [21] |
Dai L, Bevan D, Rangarajan S, et al. Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma[J/OL]. Haemophilia, 2011, 17(5): E944-E948.doi: 10.1111/j.1365-2516.2011.02491.x. |
| [22] |
Duncan CM, Gillette BP, Jacob AK, et al. Venous thromboembolism and mortality associated with tranexamic acid use during total hip and knee arthroplasty[J]. J Arthroplasty, 2015, 30(2): 272-276.
|
| [23] |
Poeran J, Rasul R, Suzuki S, et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety[J/OL]. BMJ, 2014, 349(7971): g4829. doi: 10.1136/bmj.g4829. |
| [24] |
Sabbag OD, Abdel MP, Amundson AW, et al. Tranexamic acid was safe in arthroplasty patients with a history of venous thromboembolism: a matched outcome study[J]. J Arthroplasty, 2017, 32(9, S): S246-S250.
|
| [25] |
Whiting DR, Gillette BP, Duncan CA, et al. Preliminary results suggest tranexamic acid is safe and effective in arthroplasty patients with severe comorbidities[J]. Clin Orthop Relat Res, 2014, 472(1): 66-72.
|
| [26] |
Hopewell S, Omar O, Hyde C, et al. A systematic review of the effect of red blood cell transfusion on mortality: evidence from large-scale observational studies published between 2006 and 2010[J/OL]. BMJ Open, 2013, 3(5), e002514. doi: 10.1136/bmjopen-2012-002154. |
| [27] |
Koch CG, Khandwala F, Li L, et al. Persistent effect of red cell transfusion on health-related quality of Life after cardiac surgery[J]. Ann Thorac Surg, 2006, 82(1): 13-20.
|
| [28] |
Mohnle P, Snyder-Ramos SA, et al. Multicenter study of perioperative ischemia research postoperative red blood cell transfusion and morbid outcome in uncomplicated cardiac surgery patients[J]．Intensive Care Med, 2011, 37(1):97-109.
|
| [29] |
岳辰，周宗科，裴福兴，等．中国髋、膝关节置换术围术期抗纤溶药序贯抗凝血药应用方案的专家共识[J]．中华骨与关节外科杂志，2015，8(4):281-285.
|